A critical discovery in cancer study is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This crucial malignant suppressor protein is frequently lost in several kinds of cancer, leading https://whitebookmarks.com/story22030246/vhh-fragments-reactivate-the-p53-protein-new-promising-hope-for-malignant-therapy